| Q50435623 | A Biologically Plausible Action Selection System for Cognitive Architectures: Implications of Basal Ganglia Anatomy for Learning and Decision-Making Models. |
| Q48172671 | A genetic contribution to cooperation: Dopamine-relevant genes are associated with social facilitation |
| Q64062364 | A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia |
| Q27312296 | A review of pharmacogenetic studies of substance-related disorders |
| Q41393508 | A splicing-regulatory polymorphism in DRD2 disrupts ZRANB2 binding, impairs cognitive functioning and increases risk for schizophrenia in six Han Chinese samples |
| Q33838931 | A variant in ANKK1 modulates acute subjective effects of cocaine: a preliminary study |
| Q33578546 | ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse |
| Q34135702 | Aberrant regulation of alternative pre-mRNA splicing in schizophrenia |
| Q35995415 | Addiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic system |
| Q49627711 | Advancing psychiatric pharmacogenomics using drug development paradigms |
| Q33859015 | Alcoholism and alternative splicing of candidate genes |
| Q36674776 | Allelic mRNA expression imbalance in C-type lectins reveals a frequent regulatory SNP in the human surfactant protein A (SP-A) gene |
| Q37033708 | Allelic mRNA expression of sortilin-1 (SORL1) mRNA in Alzheimer's autopsy brain tissues |
| Q34772521 | Altered regional brain volumes in elderly carriers of a risk variant for drug abuse in the dopamine D2 receptor gene (DRD2) |
| Q37320845 | Alternative splicing and disease |
| Q37560684 | Alternative splicing of G protein-coupled receptors: physiology and pathophysiology |
| Q38488535 | An association study of the genetic polymorphisms in 13 neural plasticity-related genes with semantic and episodic memories |
| Q40023182 | An association study on the polymorphisms of dopaminergic genes with working memory in a healthy Chinese Han population |
| Q35731672 | Analyzing allele specific RNA expression using mixture models |
| Q61449987 | Antipsychotic Drug Responsiveness and Dopamine Receptor Signaling; Old Players and New Prospects |
| Q35136085 | Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials |
| Q89072891 | Association analysis of the SNP (rs345476947) in the FUT2 gene with the production and reproductive traits in pigs |
| Q45826484 | Association between DRD2/DRD4 interaction and conduct disorder: a potential developmental pathway to alcohol dependence |
| Q37715708 | Association of COMT and COMT-DRD2 interaction with creative potential |
| Q37578393 | Association of COMT val158met and DRD2 G>T genetic polymorphisms with individual differences in motor learning and performance in female young adults |
| Q33854534 | Association of dopamine gene variants, emotion dysregulation and ADHD in autism spectrum disorder |
| Q37401604 | Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction |
| Q37324910 | Association study of the estrogen receptor gene ESR1 with postpartum depression--a pilot study |
| Q89534289 | Associations of the ANKK1 and DRD2 gene polymorphisms with overweight, obesity and hedonic hunger among women from the Northwest of Iran |
| Q39836000 | Aversive emotional interference impacts behavior and prefronto-striatal activity during increasing attentional control |
| Q93123575 | Axonal degeneration in Parkinson's disease - Basal ganglia circuitry and D2 receptor availability |
| Q90291761 | BDNF, COMT, and DRD2 polymorphisms and ability to return to work in adult patients with low- and high-grade glioma |
| Q38293348 | Bioinformatic analyses and conceptual synthesis of evidence linking ZNF804A to risk for schizophrenia and bipolar disorder |
| Q36813596 | COMT val158met polymorphism and molecular alterations in the human dorsolateral prefrontal cortex: Differences in controls and in schizophrenia |
| Q36359679 | CYP3A4 intronic SNP rs35599367 (CYP3A4*22) alters RNA splicing |
| Q39184902 | Cabergoline and prolactinomas: lack of association between DRD2 polymorphisms and response to treatment |
| Q34321283 | Cannabis-dependence risk relates to synergism between neuroticism and proenkephalin SNPs associated with amygdala gene expression: case-control study |
| Q28731522 | Cholesteryl Ester Transfer Protein (CETP) polymorphisms affect mRNA splicing, HDL levels, and sex-dependent cardiovascular risk |
| Q50765249 | Cognitive symptoms facilitatory for diagnoses in neuropsychiatric disorders: executive functions and locus of control. |
| Q37621304 | Common polymorphisms in dopamine-related genes combine to produce a 'schizophrenia-like' prefrontal hypoactivity |
| Q38325368 | Common single nucleotide variants underlying drug addiction: more than a decade of research. |
| Q36402504 | Common variants in DRD2 are associated with sleep duration: the CARe consortium |
| Q24631808 | Conditional routing of information to the cortex: a model of the basal ganglia's role in cognitive coordination |
| Q39422203 | Constraints on decision making: implications from genetics, personality, and addiction |
| Q43868487 | Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brain. |
| Q64777182 | DRD2 Genotype-Based Variants Modulates D2 Receptor Distribution in Ventral Striatum |
| Q36342328 | DRD2 and PPP1R1B (DARPP-32) polymorphisms independently confer increased risk for autism spectrum disorders and additively predict affected status in male-only affected sib-pair families |
| Q39017080 | DRD2 co-expression network and a related polygenic index predict imaging, behavioral and clinical phenotypes linked to schizophrenia |
| Q50695782 | DRD2 genotype predicts prefrontal activity during working memory after stimulation of D2 receptors with bromocriptine. |
| Q36471450 | DRD2 genotype-based variation of default mode network activity and of its relationship with striatal DAT binding |
| Q36054572 | DRD2 polymorphisms modulate reward and emotion processing, dopamine neurotransmission and openness to experience |
| Q34508840 | DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia |
| Q33599626 | DRD2/CHRNA5 interaction on prefrontal biology and physiology during working memory |
| Q46392449 | DRD2/DRD4 heteromerization may influence genetic susceptibility to alcohol dependence |
| Q39217375 | DRD2: Bridging the Genome and Ingestive Behavior. |
| Q34480390 | Developmental imaging genetics: linking dopamine function to adolescent behavior |
| Q43579146 | Differential mutation profiles and similar intronic TP53 polymorphisms in asbestos-related lung cancer and pleural mesothelioma |
| Q36492563 | Dissociation of working memory impairments and attention-deficit/hyperactivity disorder in the brain |
| Q34279187 | Divergent and nonuniform gene expression patterns in mouse brain |
| Q43508066 | Dopamine D2 Receptors Modulate Pyramidal Neurons in Mouse Medial Prefrontal Cortex through a Stimulatory G-Protein Pathway |
| Q38865983 | Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic study |
| Q92351278 | Dopamine D2L Receptor Deficiency Causes Stress Vulnerability through 5-HT1A Receptor Dysfunction in Serotonergic Neurons |
| Q37222842 | Dopamine DRD2 polymorphism alters reversal learning and associated neural activity |
| Q34326431 | Dopamine beta hydroxylase genotype identifies individuals less susceptible to bias in computer-assisted decision making |
| Q50781089 | Dopamine effects on human error processing depend on catechol-O-methyltransferase VAL158MET genotype. |
| Q36593856 | Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene-gene-environment interaction |
| Q35112181 | Dopamine transporter gene variant affecting expression in human brain is associated with bipolar disorder |
| Q47843882 | Dopaminergic Genetic Variation Influences Aripiprazole Effects on Alcohol Self-Administration and the Neural Response to Alcohol Cues in a Randomized Trial |
| Q47295021 | Dopaminergic polymorphisms associated with medication responsiveness of gait in Parkinson's disease. |
| Q44467061 | Drug abuse relapse rates linked to level of education: can we repair hypodopaminergic-induced cognitive decline with nutrient therapy? |
| Q81826658 | Drug therapy and personalized health care: pharmacogenomics in perspective |
| Q30465987 | Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways. |
| Q34861234 | Dysfunctional gene splicing as a potential contributor to neuropsychiatric disorders |
| Q35918802 | Effective connectivity of AKT1-mediated dopaminergic working memory networks and pharmacogenetics of anti-dopaminergic treatment |
| Q58115044 | Effects of DRD2 splicing-regulatory polymorphism and DRD4 48 bp VNTR on crack cocaine addiction |
| Q34997047 | Effects of adult exposure to bisphenol a on genes involved in the physiopathology of rat prefrontal cortex |
| Q48404644 | Endocytosis following dopamine D2 receptor activation is critical for neuronal activity and dendritic spine formation via Rabex-5/PDGFRβ signaling in striatopallidal medium spiny neurons |
| Q33889605 | Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants |
| Q44273931 | Evocative gene-parenting correlations and academic performance at first grade: an exploratory study |
| Q42852530 | Frontostriatal involvement in task switching depends on genetic differences in d2 receptor density. |
| Q45782081 | Functional connectivity in healthy subjects is nonlinearly modulated by the COMT and DRD2 polymorphisms in a functional system-dependent manner. |
| Q37092462 | Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia. |
| Q33711011 | Functional variation of the dopamine D2 receptor gene is associated with emotional control as well as brain activity and connectivity during emotion processing in humans |
| Q90058245 | Genetic Influence on Efficacy of Pharmacotherapy for Pediatric Attention-Deficit/Hyperactivity Disorder: Overview and Current Status of Research |
| Q35563650 | Genetic Polymorphisms in the Dopamine Receptor 2 Predict Acute Pain Severity after Motor Vehicle Collision |
| Q37384257 | Genetic contributions to avoidance-based decisions: striatal D2 receptor polymorphisms |
| Q36071808 | Genetic factors modulating the response to stimulant drugs in humans |
| Q50785917 | Genetic factors of reaction time performance: DRD4 7-repeat allele associated with slower responses. |
| Q35153945 | Genetic neuropathology of schizophrenia: new approaches to an old question and new uses for postmortem human brains |
| Q43287374 | Genetic susceptibility in solvent induced neurobehavioral effects. |
| Q46126668 | Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms |
| Q28076923 | Genetic variation and dopamine D2 receptor availability: a systematic review and meta-analysis of human in vivo molecular imaging studies |
| Q45296043 | Genetic variation and the D2 dopamine receptor: implications for the treatment of neuropsychiatric disease |
| Q28606617 | Genetic variations in the serotonergic system contribute to amygdala volume in humans |
| Q37201805 | Genetically determined interaction between the dopamine transporter and the D2 receptor on prefronto-striatal activity and volume in humans. |
| Q33533750 | Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance |
| Q46540085 | Genetically-Driven Enhancement of Dopaminergic Transmission Affects Moral Acceptability in Females but Not in Males: A Pilot Study |
| Q37376944 | HIV-related cognitive impairment shows bi-directional association with dopamine receptor DRD1 and DRD2 polymorphisms in substance-dependent and substance-independent populations |
| Q35837686 | Haplotype polymorphism in the alpha-2B-adrenergic receptor gene influences response inhibition in a large Chinese sample |
| Q38396102 | Human N-acetyltransferase 1 *10 and *11 alleles increase protein expression through distinct mechanisms and associate with sulfamethoxazole-induced hypersensitivity |
| Q64999981 | Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia. |
| Q94316746 | Hypomania and saccadic changes in Parkinson's disease: influence of D2 and D3 dopaminergic signalling |
| Q54562217 | Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients. |
| Q26798859 | Individual predictors of sensorimotor adaptability |
| Q33784183 | Inherited polymorphisms in hyaluronan synthase 1 predict risk of systemic B-cell malignancies but not of breast cancer |
| Q35950814 | Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis |
| Q48528143 | Interaction between the obesity-risk gene FTO and the dopamine D2 receptor gene ANKK1/TaqIA on insulin sensitivity |
| Q55378329 | Interaction of childhood urbanicity and variation in dopamine genes alters adult prefrontal function as measured by functional magnetic resonance imaging (fMRI). |
| Q57818789 | Interactions Between Regulatory Variants in CYP7A1 (Cholesterol 7α-Hydroxylase) Promoter and Enhancer Regions Regulate CYP7A1 Expression |
| Q37342341 | Interactions of genetic variants reveal inverse modulation patterns of dopamine system on brain gray matter volume and resting-state functional connectivity in healthy young adults |
| Q53439390 | Intra-accumbens Raclopride Administration Prevents Behavioral Changes Induced by Intermittent Access to Sucrose Solution. |
| Q33803212 | Intronic SNP in ESR1 encoding human estrogen receptor alpha is associated with brain ESR1 mRNA isoform expression and behavioral traits |
| Q34662050 | Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse |
| Q35035569 | Inverted-U-shaped dopamine actions on human working memory and cognitive control |
| Q39211780 | Lack of influence of DAT1 and DRD2 gene variants on antidepressant response in generalized anxiety disorder |
| Q34761070 | Linguistic grammar learning and DRD2-TAQ-IA polymorphism. |
| Q27002640 | Lipid phosphate phosphatase (LPP3) and vascular development |
| Q43514569 | Load-dependent dysfunction of the putamen during attentional processing in patients with clinically isolated syndrome suggestive of multiple sclerosis. |
| Q41816848 | Measuring cis-acting regulatory variants genome-wide: new insights into expression genetics and disease susceptibility |
| Q33676705 | MicroRNA-9 and microRNA-326 regulate human dopamine D2 receptor expression, and the microRNA-mediated expression regulation is altered by a genetic variant |
| Q34212558 | Missing heritability of common diseases and treatments outside the protein-coding exome |
| Q33800945 | Moderator effects of working memory on the stability of ADHD symptoms by dopamine receptor gene polymorphisms during development. |
| Q56967502 | Modulation of orbitofrontal-striatal reward activity by dopaminergic functional polymorphisms contributes to a predisposition to alcohol misuse in early adolescence |
| Q48082677 | NCAM1-TTC12-ANKK1-DRD2 gene cluster and the clinical and genetic heterogeneity of adults with ADHD. |
| Q36353466 | Network-Dependent Modulation of COMT and DRD2 Polymorphisms in Healthy Young Adults. |
| Q35761494 | Neurogenetic and Neuroimaging Evidence for a Conceptual Model of Dopaminergic Contributions to Obesity |
| Q24602643 | Neurogenetics and pharmacology of learning, motivation, and cognition |
| Q27024858 | Neuropsychopharmacology and neurogenetic aspects of executive functioning: should reward gene polymorphisms constitute a diagnostic tool to identify individuals at risk for impaired judgment? |
| Q33843327 | Neurotensin receptor 1 gene (NTSR1) polymorphism is associated with working memory |
| Q38729316 | New Repeat Polymorphism in the AKT1 Gene Predicts Striatal Dopamine D2/D3 Receptor Availability and Stimulant-Induced Dopamine Release in the Healthy Human Brain |
| Q28755491 | Next generation tools for the annotation of human SNPs |
| Q34052418 | Next-generation DNA sequencing-based assay for measuring allelic expression imbalance (AEI) of candidate neuropsychiatric disorder genes in human brain |
| Q64253433 | No association between polymorphisms in the promoter region of dopamine receptor D2 gene and schizophrenia in the northern Chinese Han population: A case-control study |
| Q44959646 | Nonlinear response of the anterior cingulate and prefrontal cortex in schizophrenia as a function of variable attentional control |
| Q37970016 | Novel dopamine D2 receptor signaling through proteins interacting with the third cytoplasmic loop |
| Q41990893 | Novel sequence variations in LAMA2 andSGCG genes modulating cis-acting regulatory elements and RNA secondary structure |
| Q48846561 | On the molecular genetics of flexibility: the case of task-switching, inhibitory control and genetic variants |
| Q35439069 | Overlapping dopaminergic pathway genetic susceptibility to heroin and cocaine addictions in African Americans |
| Q37445821 | PTSD risk associated with a functional DRD2 polymorphism in heroin-dependent cases and controls is limited to amphetamine-dependent individuals |
| Q36747324 | Paradoxical dopaminergic drug effects in extraversion: dose- and time-dependent effects of sulpiride on EEG theta activity |
| Q92705761 | Personality Traits or Genetic Determinants-Which Strongly Influences E-Cigarette Users? |
| Q34970259 | PharmGKB summary: dopamine receptor D2 |
| Q37344782 | Pharmacogenetic tests for antipsychotic medications: clinical implications and considerations |
| Q37636030 | Pharmacogenetics of D2 dopamine receptor gene in prolactin-secreting pituitary adenomas |
| Q50266015 | Pharmacogenetics of methylphenidate response and tolerability in attention-deficit/hyperactivity disorder. |
| Q35120999 | Pharmacogenomic biomarkers: validation needed for both the molecular genetic mechanism and clinical effect |
| Q38100731 | Pharmacogenomics can improve antipsychotic treatment in schizophrenia |
| Q35654120 | Pharmacogenomics of the RNA world: structural RNA polymorphisms in drug therapy |
| Q37427023 | Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues |
| Q46047646 | Polymorphisms in the dopamine receptor 2 gene region influence improvements during working memory training in children and adolescents |
| Q39635275 | Polypyrimidine tract-binding protein 1 regulates the alternative splicing of dopamine receptor D2 |
| Q36225903 | Posttraumatic Brain Injury Cognitive Performance Is Moderated by Variation Within ANKK1 and DRD2 Genes |
| Q41657879 | Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status |
| Q30498976 | Prefrontal and striatal dopaminergic genes predict individual differences in exploration and exploitation |
| Q36164951 | Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis |
| Q41867856 | Prefronto-striatal physiology is associated with schizotypy and is modulated by a functional variant of DRD2 |
| Q37258345 | Promoter polymorphisms in ACE (angiotensin I-converting enzyme) associated with clinical outcomes in hypertension |
| Q35097990 | Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood |
| Q35849067 | RNA sequencing of transcriptomes in human brain regions: protein-coding and non-coding RNAs, isoforms and alleles |
| Q40519250 | Rapporteur summaries of plenary, symposia, and oral sessions from the XXIIIrd World Congress of Psychiatric Genetics Meeting in Toronto, Canada, 16-20 October 2015. |
| Q36835168 | Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement |
| Q33894630 | Relationship of striatal dopamine synthesis capacity to age and cognition |
| Q37059645 | Review: The role of LOXL1 in exfoliation syndrome/glaucoma |
| Q37228046 | Role of dopamine in the motivational and cognitive control of behavior |
| Q42054665 | SNP-SNP interactions as risk factors for aggressive prostate cancer. |
| Q37537684 | Selective updating of working memory content modulates meso-cortico-striatal activity |
| Q38243174 | Should we keep on? Looking into pharmacogenomics of ADHD in adulthood from a different perspective. |
| Q43025010 | Strain-specific proportion of the two isoforms of the dopamine D2 receptor in the mouse striatum: associated neural and behavioral phenotypes. |
| Q36453185 | Striatal dopamine D₂/D₃ receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans |
| Q28651994 | Stuttering candidate genes DRD2 but not SLC6A3 is associated with developmental dyslexia in Chinese population |
| Q35961970 | Synaptic activity unmasks dopamine D2 receptor modulation of a specific class of layer V pyramidal neurons in prefrontal cortex |
| Q34689268 | Synaptic signaling and aberrant RNA splicing in autism spectrum disorders |
| Q34279073 | The 2nd Schizophrenia International Research Society Conference, 10-14 April 2010, Florence, Italy: summaries of oral sessions |
| Q34156681 | The 8th annual pharmacogenetics in psychiatry meeting report |
| Q48794168 | The AKT1 gene is associated with attention and brain morphology in schizophrenia. |
| Q45969403 | The ANKK1 kinase gene and psychiatric disorders. |
| Q42477109 | The ANKK1 protein associated with addictions has nuclear and cytoplasmic localization and shows a differential response of Ala239Thr to apomorphine |
| Q36341795 | The ANKK1/DRD2 locus is a genomic substrate for affective priming and recognition of angry faces. |
| Q48026564 | The Addiction-Related Protein ANKK1 is Differentially Expressed During the Cell Cycle in Neural Precursors. |
| Q26764813 | The Association Between Genetic Variants in the Dopaminergic System and Posttraumatic Stress Disorder: A Meta-Analysis |
| Q37434854 | The Association of DRD2 with Insight Problem Solving |
| Q64980739 | The Beneficial Effect of Acute Exercise on Motor Memory Consolidation is Modulated by Dopaminergic Gene Profile. |
| Q34490946 | The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery |
| Q43267084 | The association between dopamine DRD2 polymorphisms and working memory capacity is modulated by a functional polymorphism on the nicotinic receptor gene CHRNA4. |
| Q91839306 | The association between perinatal hypoxia exposure and externalizing symptoms and children's decision making in conditions of uncertainty is moderated by DRD2 genotype |
| Q33579769 | The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction |
| Q37661379 | The dopaminergic reward system and leisure time exercise behavior: a candidate allele study |
| Q54947826 | The frequency of DRD2 rs1076560 and OPRM1 rs1799971 in substance use disorder patients from the United Arab Emirates. |
| Q50345695 | The genetic architecture of autism spectrum disorders (ASDs) and the potential importance of common regulatory genetic variants |
| Q33635632 | The impact of common dopamine D2 receptor gene polymorphisms on D2/3 receptor availability: C957T as a key determinant in putamen and ventral striatum |
| Q36898305 | The influence of dopaminergic gene variants on decision making in the ultimatum game |
| Q38208293 | The role of prefrontal catecholamines in attention and working memory |
| Q30277983 | The significant association of Taq1A genotypes in DRD2/ANKK1 with smoking cessation in a large-scale meta-analysis of Caucasian populations |
| Q64108690 | Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates |
| Q39746409 | Tridimensional personalities and polymorphism of dopamine D2 receptor among heroin addicts |
| Q64230912 | Unravelling the interaction between the and genes, personality traits and concussion risk |
| Q42201173 | Updated findings of the association and functional studies of DRD2/ANKK1 variants with addictions |
| Q27011768 | Use of magnetic resonance imaging in pharmacogenomics |
| Q33399843 | Using genetic data in cognitive neuroscience: from growing pains to genuine insights |
| Q34010238 | Valenced action/inhibition learning in humans is modulated by a genetic variant linked to dopamine D2 receptor expression |
| Q37236402 | Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents |
| Q37024867 | Variation in Dopamine D2 and Serotonin 5-HT2A Receptor Genes is Associated with Working Memory Processing and Response to Treatment with Antipsychotics |
| Q42949475 | What is a functional genetic polymorphism? Defining classes of functionality |
| Q28681164 | Whole transcriptome RNA-Seq allelic expression in human brain |
| Q50975311 | [Schizophrenia, genetics and cognition]. |
| Q35913120 | mRNA transcript diversity creates new opportunities for pharmacological intervention |